CAB/ESCRO Committee

SARS-CoV-2 or COVID-19 Related Research

Please let your Biosafety Officer know of ANY SARS-CoV-2 or COVID-19 related research you were approved to conduct by your PI, DLC Head and MIT Administration, or are planning to submit. Most of the research involving recombinant parts of SARS-CoV-2, SARS-CoV (also referred to as SARS-CoV-1), or MERS-CoV requires registration with the CAB (MIT Committee on Assessment of Biohazards & Embryonic Stem Cell Research Oversight). Please plan accordingly and email BSP@mit.edu for a proper risk assessment.